NCT03978832 Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone Status COMPLETED Phase PHASE4
NCT03975400 Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis Status COMPLETED Phase NA
NCT03974620 Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia Status NOT_YET_RECRUITING Phase NA
NCT03973853 How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia Status WITHDRAWN Phase NA
NCT03967431 Effects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia Status COMPLETED Phase NA
NCT03965598 Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group Status UNKNOWN Phase N/A
NCT03953664 The Effects of Three Different Modalities of Exercise in Patients With Schizophrenia Status COMPLETED Phase NA
NCT03943537 Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders Status COMPLETED Phase PHASE2
NCT03940898 The Mid-term Effect of Repeated Transcranial Magnetic Stimulation on Schizophrenia Status COMPLETED Phase NA
NCT03935854 Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness Status COMPLETED Phase NA
NCT03930225 Effectiveness of A Stigma Directed Interventional Program in Schizophrenia Status COMPLETED Phase NA
NCT03929497 Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms Status TERMINATED Phase PHASE2